Page 159 - Pagetit
P. 159

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE




                   CYP2D6
                   Opioid metabolizing enzymes are also strong candidate genes for involvement
                   in susceptibility. The most significant finding in opioid dependence is the
                   association found between oral codeine dependence and the metabolizing
                   enzyme CYP2D6 (Tyndale, Droll & Sellers, 1997). Many opioids (e.g. codeine,
                   oxycodone and hydrocodone) are metabolized by CYP2D6 to metabolites of
                   increased activity, principally morphine. It is estimated that 4–10% of
                   Caucasians lack CYP2D6 activity due to inheritance of two non-functional
                   alleles. Tyndale, Droll & Sellers (1997) found that of a group of people with
                   dependence on oral opiates, there were no poor metabolizers of CYP2D6
                   (Fisher’s exact test, p < or = 0.05). This is in contrast with 4% of people in the
                   non-dependent group being poor metabolizers of CYP2D6, suggesting that the
                   CYP2D6 variant genotype offers protection against oral opioid dependence.
                   However, this finding remains controversial (Mikus et al., 1998).

                   Genetics of the combined risk of dependence on tobacco,
                   alcohol, opioids and other psychoactive substances
                   Heritability of substance dependence
                   Genetic risk influences the predisposition to use and to the development of
                   dependence on alcohol, tobacco and opioids individually. However, there is
                   also a genetic contribution to use of, and dependence on, a combination of
                   alcohol, tobacco and other substances (Carmelli et al., 1992; Reed et al., 1994;
                   Swan, Carmelli & Cardon, 1996, 1997; Daeppen et al., 2000; Hopfer, Stallings
                   & Hewitt, 2001; Tsuang et al., 2001).
                     The classic adoption studies of Cadoret have been instrumental in defining
                   the importance of genetic factors in substance abuse (Cadoret et al., 1986,
                   1995). These studies demonstrated that substance abuse was significantly
                   greater in adoptees whose biological parents were dependent on alcohol or
                   other psychoactive substances, or who had a personality disorder. This led
                   to a model in which two genetic factors and an independent, environmental
                   factor from the adoptive family increase the risk of substance abuse.
                     The co-occurrence of lifetime tobacco and alcohol dependence has a
                   substantial genetic correlation suggesting a common genetic vulnerability
                   (True et al., 1999). Environmental features have a large influence on the
                   initiation of alcohol and tobacco use in adolescents, whereas alcohol and
                   tobacco use in slightly older young adults was more influenced by genetic
                   risk factors (Koopmans, van Doornen & Boomsma, 1997). People who smoke
                   are also at greater risk for severe alcohol dependence (Daeppen et al., 2000).
                   Significant genetic correlations exist between problem drinking and ever
                   smoking or using at least one half-pack (10 cigarettes) per day (Hopfer,
                   Stallings & Hewitt, 2001). The shared genetic influence on alcohol use and
                   smoking in women is clearest for those subjects with the highest severity of
                   alcohol use (Hopfer, Stallings & Hewitt, 2001).


                                                  138




          Chapter_5                138                             19.1.2004, 11:45
   154   155   156   157   158   159   160   161   162   163   164